Characterization of epileptic spiking associated with brain amyloidosis in APP/PS1 mice
Gureviciene, I., Ishchenko, I., Ziyatdinova, S., Jin, N., Lipponen, A., Gurevicius, K., & Tanila, H. (2019). Characterization of epileptic spiking associated with brain amyloidosis in APP/PS1 mice. Frontiers in Neurology, 10, 1151. https://doi.org/10.3389/fneur.2019.01151
Published in
Frontiers in NeurologyAuthors
Date
2019Copyright
© 2019 Gureviciene, Ishchenko, Ziyatdinova, Jin, Lipponen, Gurevicius
and Tanila
Epileptic activity without visible convulsions is common in Alzheimer’s disease (AD) and may contribute adversely to the disease progress and symptoms. Transgenic mice with amyloid plaque pathology also display epileptic seizures, but those are too infrequent to assess the effect of anti-epileptic treatments. Besides spontaneous seizures, these mice also display frequent epileptic spiking in epidural EEG recordings, and these have provided a means to test potential drug treatment to AD-related epilepsy. However, the origin of EEG spikes in transgenic AD model mice has remained elusive, which makes it difficult to relate electrophysiology with underlying pathology at the cellular and molecular level. Using multiple cortical and subcortical electrodes in freely moving APP/PS1 transgenic mice and their wild-type littermates, we identified several types of epileptic spikes among over 15 800 spikes visible with cortical screw electrodes based on their source localization. Cortical spikes associated with muscle twitches, cortico-hippocampal spikes, and spindle and fast-spindle associated spikes were present equally often in both APP/PS1 and wild-type mice, whereas pure cortical spikes were slightly more common in APP/PS1 mice. In contrast, spike-wave discharges, cortico-hippocampal spikes with afterhyperpolarization and giant spikes were seen almost exclusively in APP/PS1 mice but only in a subset of them. Interestingly, different subtypes of spikes responded differently to anti-epileptic drugs ethosuximide and levetiracetam. From the translational point most relevant may be the giant spikes generated in the hippocampus that reached an amplitude up to +/- 5 mV in the hippocampal channel. As in AD patients, they occurred exclusively during sleep. Further, we could demonstrate that a high number of giant spikes in APP/PS1 mice predicts seizures. These data show that by only adding a pair of hippocampal deep electrodes and EMG to routine cortical epidural screw electrodes and by taking into account underlying cortical oscillations, one can drastically refine the analysis of cortical spike data. This new approach provides a powerful tool to preclinical testing of potential new treatment options for AD related epilepsy.
...
Publisher
Frontiers MediaISSN Search the Publication Forum
1664-2295Keywords
Publication in research information system
https://converis.jyu.fi/converis/portal/detail/Publication/33421881
Metadata
Show full item recordCollections
Additional information about funding
The research was supported by Sigrid Juselius Foundation (Finland), Finnish Cultural Foundation, Center for International Mobility (CIMO) Finland.License
Related items
Showing items with similar title or keywords.
-
Epilepsy in neuropathologically verified Alzheimer's disease
Rauramaa, Tuomas; Saxlin, Anna; Lohvansuu, Kaisa; Alafuzoff, Irina; Pitkänen, Asla; Soininen, Hilkka (Elsevier Ltd., 2018)Purpose Subjects with Alzheimer’s disease (AD) have been shown to be at a higher risk for epilepsy. The vast majority of the previous studies have not included a full neuropathological examination. Methods The objective ... -
Active Gains in brain Using Exercise During Aging (AGUEDA) : protocol for a randomized controlled trial
Solis-Urra, Patricio; Molina-Hidalgo, Cristina; García-Rivero, Yolanda; Costa-Rodriguez, Claudia; Mora-Gonzalez, Jose; Fernandez-Gamez, Beatriz; Olvera-Rojas, Marcos; Coca-Pulido, Andrea; Toval, Angel; Bellón, Darío; Sclafani, Alessandro; Martín-Fuentes, Isabel; Triviño-Ibañez, Eva María; de Teresa, Carlos; Huang, Haiqing; Grove, George; Hillman, Charles H.; Kramer, Arthur F.; Catena, Andrés; Ortega, Francisco B.; Gómez-Río, Manuel; Erickson, Kirk I.; Esteban-Cornejo, Irene (Frontiers Media, 2023)Alzheimer’s disease is currently the leading cause of dementia and one of the most expensive, lethal and severe diseases worldwide. Age-related decline in executive function is widespread and plays a key role in subsequent ... -
Reduced firing rates of pyramidal cells in the frontal cortex of APP/PS1 can be restored by acute treatment with levetiracetam
Klee, Jan L.; Kiliaan, Amanda J.; Lipponen, Arto; Battaglia, Francesco P. (Elsevier, 2020)In recent years aberrant neural oscillations in various cortical areas have emerged as a common physiological hallmark across mouse models of amyloid pathology and patients with Alzheimer's disease. However, much less is ... -
Physical Performance and Amyloid-β in Humans : A Systematic Review and Meta-Analysis of Observational Studies
Solis-Urra, Patricio; Rodriguez-Ayllon, María; Álvarez-Ortega, Miriam; Molina-Hidalgo, Cristina; Molina-Garcia, Pablo; Arroyo-Ávila, Cristina; García-Hermoso, Antonio; Collins, Audrey M.; Jain, Shivangi; Gispert, Juan Domingo; Liu-Ambrose, Teresa; Ortega, Francisco B.; Erickson, Kirk I.; Esteban-Cornejo, Irene (IOS Press, 2023)Background: Accumulation of amyloid-β (Aβ) plaques is one of the main features of Alzheimer’s disease (AD). Physical performance has been related to dementia risk and Aβ, and it has been hypothesized as one of the mechanisms ... -
Physical activity may not be associated with long‐term risk of dementia and Alzheimer’s disease
Kunutsor, Setor K.; Laukkanen, Jari A.; Kauhanen, Jussi; Willeit, Peter (Wiley, 2021)Background While it is well established that physical activity is associated with reduced risk of vascular and non‐vascular outcomes as well as mortality, evidence on the association between physical activity and dementia ...